Literature DB >> 21896779

Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage response.

Douangsone D Vadysirisack1, Franziska Baenke, Benjamin Ory, Kui Lei, Leif W Ellisen.   

Abstract

Exquisite control of the level and activity of p53 are required in order to preserve cellular homeostasis following DNA damage. How this regulation is integrated with other key metabolic pathways in vivo is poorly understood. Here, we describe an endogenous feedback circuit for regulation of p53 through its transcriptional target gene, Redd1, a stress-induced inhibitor of TOR complex 1 (TORC1) activity. Cells and tissues of Redd1(-/-) mice exhibit enhanced sensitivity to ionizing radiation and chemotherapy treatment, which we demonstrate is attributable to abnormally increased p53 protein level and activity in the absence of Redd1. We find that deregulation of p53 in this setting is not due to failed DNA repair or to increased p53 stabilization but, instead, to increased p53 translation. We show that Redd1 loss leads to elevated mammalian TORC1 (mTORC1) activity, which explains the increased p53 translation and protein levels. Together, these findings suggest that REDD1-mediated suppression of mTORC1 activity exerts feedback control on p53, thereby limiting the apoptotic response and contributing to cellular survival following DNA damage. This work therefore defines a role for REDD1 in the control of p53 in vivo, with potential therapeutic implications for cancer and for the variety of genetic diseases involving TOR pathway signaling components.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896779      PMCID: PMC3209328          DOI: 10.1128/MCB.05541-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation.

Authors:  L Fu; S Benchimol
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

3.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

Review 4.  mTOR links oncogenic signaling to tumor cell metabolism.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

5.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

6.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

7.  MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.

Authors:  V A Flørenes; G M Maelandsmo; A Forus; A Andreassen; O Myklebost; O Fodstad
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

8.  Inhibition of mTORC1 activity by REDD1 induction in myeloma cells resistant to bortezomib cytotoxicity.

Authors:  Olivier Decaux; Monique Clément; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Loïc Campion; Hervé Avet Loiseau; Stéphane Minvielle
Journal:  Cancer Sci       Date:  2009-12-11       Impact factor: 6.716

9.  The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila.

Authors:  Jan H Reiling; Ernst Hafen
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

10.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

View more
  20 in total

1.  The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis.

Authors:  Batzaya Davaadelger; Ricardo E Perez; Yalu Zhou; Lei Duan; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

2.  Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.

Authors:  Yujun Wang; Ernest Han; Quanhua Xing; Jin Yan; Amanda Arrington; Charles Wang; Dylan Tully; Claudia M Kowolik; David M Lu; Paul H Frankel; Jing Zhai; Wei Wen; David Horne; M L Richard Yip; John H Yim
Journal:  Cancer Lett       Date:  2014-12-25       Impact factor: 8.679

3.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

4.  Ninjurin1, a target of p53, regulates p53 expression and p53-dependent cell survival, senescence, and radiation-induced mortality.

Authors:  Seong-Jun Cho; Andrea Rossi; Yong-Sam Jung; Wensheng Yan; Gang Liu; Jin Zhang; Min Zhang; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

5.  The complexity of p53-mediated metabolic regulation in tumor suppression.

Authors:  Yanqing Liu; Wei Gu
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 17.012

6.  Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.

Authors:  Julie Sesen; Perrine Dahan; Sarah J Scotland; Estelle Saland; Van-Thi Dang; Anthony Lemarié; Betty M Tyler; Henry Brem; Christine Toulas; Elizabeth Cohen-Jonathan Moyal; Jean-Emmanuel Sarry; Nicolas Skuli
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1.

Authors:  Jogitha Selvarajah; Androulla Elia; Veronica A Carroll; Abdeladim Moumen
Journal:  Oncotarget       Date:  2015-01-01

8.  REDD1 Is Essential for Optimal T Cell Proliferation and Survival.

Authors:  Emma L Reuschel; JiangFang Wang; Debra K Shivers; Karuppiah Muthumani; David B Weiner; Zhengyu Ma; Terri H Finkel
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  A new posttranslational regulation of REDD1/DDIT4 through cleavage by caspase 3 modifies its cellular function.

Authors:  A Puissant; N Fenouille; G Robert; A Jacquel; C F Bassil; P Colosetti; F Luciano; P Auberger
Journal:  Cell Death Dis       Date:  2014-07-24       Impact factor: 8.469

10.  Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblasts.

Authors:  Deborah L Grainger; Lydia Kutzler; Sharon L Rannels; Scot R Kimball
Journal:  F1000Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.